Screener
Jade Biosciences
JBIOJade Biosciences is a clinical-stage biopharmaceutical company focused on developing novel biologic therapies for autoimmune diseases.
Earnings
Next report
Aug 12, 2026 (In 2 days)EPS estimate-$0.66
Financials
Q1 2026Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
Jade Biosciences is a clinical-stage biopharmaceutical company focused on developing novel biologic therapies for autoimmune diseases. The company leverages protein engineering to create monoclonal antibodies with improved potency and extended half-lives compared to existing treatments. Its core value proposition centers on delivering enhanced clinical activity and more convenient subcutaneous dosing regimens for patients with high unmet medical needs.
Competitive position
Clinical-stage developer focusing on best-in-class biologic profiles through half-life extension and increased binding affinity.
GeographiesUnited States, New Zealand
Customer segmentsPatients, Healthcare Providers
Business modelDrug Development, IP Licensing
SuppliersContract Research Organizations, Contract Manufacturing Organizations, Antibody Discovery Platforms
CustomersSpecialty Pharmacies, Hospitals, Infusion Centers
CountryUnited States of America
Listed2025
CEOTom Frohlich
SectorHealthcare
IndustryBiotechnology
Websitejadebiosciences.com
FilingsSEC EDGAR
FAQ
- What is Jade Biosciences's market cap?
- Jade Biosciences (JBIO) has a market capitalization of $1.4B and trades on NASDAQ.
- Who are Jade Biosciences's competitors?
- Jade Biosciences's key competitors include Vera Therapeutics, Inc., Vertex Pharmaceuticals Incorporated, Travere Therapeutics, Inc., and others. These companies compete in similar markets and product categories.
- Who does Jade Biosciences partner with?
- Jade Biosciences's notable partners include Paragon Therapeutics, Inc., WuXi Biologics, Thermo Fisher Scientific, Inc., and others.
- What subsidiaries does Jade Biosciences have?
- Jade Biosciences's subsidiaries include Jade Biosciences, LLC.
- Where is Jade Biosciences headquartered?
- Jade Biosciences is headquartered in United States of America. It has been publicly traded since 2025.